Davide Moschese
Overview
Explore the profile of Davide Moschese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1024
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ciccullo A, Baldin G, Cervo A, Moschese D, Lagi F, Cossu M, et al.
J Antimicrob Chemother
. 2024 Oct;
80(1):175-177.
PMID: 39478330
Objectives: We compared the effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide fumarate (BIC/FTC/TAF) and dolutegravir plus lamivudine (DTG + 3TC) in our cohort of treatment-naive people with HIV (PWH). Methods: In...
2.
Mazzotta V, Nozza S, Lanini S, Moschese D, Tavelli A, Rossotti R, et al.
EBioMedicine
. 2024 Aug;
107:105289.
PMID: 39178746
Background: Severe and prolonged mpox courses have been described during the 2022-2023 outbreak. Identifying predictors of severe evolution is crucial for improving management and therapeutic strategies. We explored the predictors...
3.
Rizzo A, Moschese D, Salari F, Giacomelli A, Cavallo A, Cossu M, et al.
J Med Virol
. 2024 Aug;
96(8):e29852.
PMID: 39166456
The association between human papillomavirus (HPV) and other sexually transmitted infections (STIs) in anal lesions still remains unclear. Aim of the study was to evaluate the prevalence of simultaneous infection...
4.
Rizzo A, Giacomelli A, Moschese D, Mileto D
Infect Dis (Lond)
. 2024 Aug;
56(10):928-929.
PMID: 39105783
No abstract available.
5.
Moschese D, Lazzarin S, Colombo M, Caruso F, Giacomelli A, Antinori S, et al.
Viruses
. 2024 Jun;
16(6).
PMID: 38932243
Pre-exposure prophylaxis (PrEP) is a pivotal intervention among HIV prevention strategies. We aimed to narratively revise the topic of HIV acute infection in the setting of PrEP exposure with a...
6.
Iannone V, Ciccullo A, Moschese D, Giacomelli A, Fabbiani M, Lagi F, et al.
J Acquir Immune Defic Syndr
. 2024 May;
96(2):e10-e11.
PMID: 38771757
No abstract available.
7.
Rizzo A, Dalu D, Moschese D, Giacomelli A
J Med Virol
. 2024 May;
96(5):e29677.
PMID: 38751160
No abstract available.
8.
Giacomelli A, Cattaneo D, Pozza G, Moschese D, Cossu M, Dalu D, et al.
J Antimicrob Chemother
. 2024 Apr;
79(7):1708-1709.
PMID: 38661237
No abstract available.
9.
Moschese D, Raccagni A, Giacomelli A, Piralla A, Rossotti R, Raimondi A, et al.
Clin Infect Dis
. 2024 Apr;
80(1):234-236.
PMID: 38573320
No abstract available.
10.
Mancon A, Raccagni A, Gagliardi G, Moschese D, Rizzo A, Giacomelli A, et al.
Emerg Microbes Infect
. 2024 Apr;
13(1):2337666.
PMID: 38572513
(MPXV) infection confirmation needs reliable polymerase chain reaction (PCR) assays; in addition, viral clade attribution is a key factor in containment measures, considering a more severe syndrome in clade I...